| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 01/31/2012 | US8106003 Peptides and methods for the treatment of inflammatory disease |
| 01/31/2012 | US8105847 Nano-sized optical fluorescence labels and uses thereof |
| 01/31/2012 | CA2393682C Depsipeptide and congeners thereof for use as immunosuppressants |
| 01/31/2012 | CA2226087C Nucleotide and protein sequences of vertebrate delta genes and methods based thereon |
| 01/26/2012 | WO2012012667A2 Methods and compositions for modification of a hla locus |
| 01/26/2012 | WO2012012469A2 Signal biomarkers |
| 01/26/2012 | WO2012011100A1 Peptides based on the transmembrane domain of a toll-like receptor (tlr) for treatment of tlr-mediated diseases |
| 01/26/2012 | WO2012010668A1 Novel substrates the fluorescence of which is suppressed, preparation thereof, and use thereof for identifying, detecting, and assaying legionella pneumophilia |
| 01/26/2012 | WO2012010266A1 Antimicrobial peptide, branched forms thereof and their use in the treatment of bacteria infections |
| 01/26/2012 | WO2012010092A1 Preparation method and use of a crystal of a peptide substance |
| 01/26/2012 | WO2011143280A3 Peptide-based inhibitor of interleukin-10 or interferon-gamma signaling |
| 01/26/2012 | WO2011115420A3 Adhesive extracellular matrix mimetic |
| 01/26/2012 | US20120022371 Compositions and methods for detecting and treating tumors containing acidic areas |
| 01/26/2012 | US20120022006 B-lymphocyte stimulator binding polypeptides and methods based thereon |
| 01/26/2012 | US20120022000 Use of a peptide in the treatment or prevention of metastasis |
| 01/26/2012 | US20120021995 Polypeptides that Bind TRAIL-R1 and TRAIL-R2 |
| 01/26/2012 | US20120021994 Novel cancer antigen eef2 |
| 01/26/2012 | US20120021990 Peptides useful as dual caspase-2/-6 inhibitors and their biological applications |
| 01/26/2012 | US20120021975 Antibiotic peptides |
| 01/26/2012 | US20120021973 Peptides for Treatment of Obesity |
| 01/26/2012 | US20120021972 Peptidomimetics with glucagon antagonistic and glp 1 agonistic activities |
| 01/26/2012 | US20120021530 HETEROGENEOUS FOLDAMERS CONTAINING alpha, beta, and/or gamma-AMINO ACIDS |
| 01/26/2012 | US20120021454 Rapid fret-based diagnosis of bacterial pathogens |
| 01/26/2012 | US20120021446 Evaluation Peptide For Use In Quantification Of Protein Using Mass Spectrometer, Artificial Standard Protein, And Method For Quantifying Protein |
| 01/26/2012 | US20120021430 Functional lipid constructs |
| 01/26/2012 | US20120020990 Isolated mammalian monocyte cell genes; related reagents |
| 01/26/2012 | US20120020977 Pancreatic cancer genes |
| 01/26/2012 | US20120020964 Antibodies for Norovirus |
| 01/26/2012 | US20120020940 Antimicrobial peptides |
| 01/26/2012 | US20120020904 Novel proteasome-activating lightening peptides and compositions containing same |
| 01/26/2012 | US20120020893 Intravascular Imaging Device and Uses Thereof |
| 01/26/2012 | US20120020882 Peptide-based compounds |
| 01/26/2012 | US20120020881 Triaryl-sulphonium compounds, kit and methods for labeling positron emitting isotopes |
| 01/26/2012 | CA2813219A1 Novel substrates the fluorescence of which is suppressed, preparation thereof, and use thereof for identifying, detecting, and assaying legionella pneumophilia |
| 01/26/2012 | CA2805989A1 Peptides based on the transmembrane domain of a toll-like receptor (tlr) for treatment of tlr-mediated diseases |
| 01/26/2012 | CA2805962A1 Crystal of peptide substance as well as the preparation method and use thereof |
| 01/26/2012 | CA2805794A1 Signal biomarkers |
| 01/26/2012 | CA2805442A1 Methods and compositions for modification of an hla locus |
| 01/25/2012 | EP2409985A2 Inhibitors de serine proteases, especially of the NS3 protease of the hepatitis C virus |
| 01/25/2012 | EP2409707A1 Polymer-based sustained release device |
| 01/25/2012 | EP2409579A1 Antimicrobial peptide, branched forms and uses thereof for the cure of bacteria infections |
| 01/25/2012 | EP2408913A1 Neil3 peptides and vaccines including the same |
| 01/25/2012 | EP2408806A1 Analogs of temporin-sha, and uses thereof |
| 01/25/2012 | EP2408803A1 Inhibitors of viral integrase and methods of use |
| 01/25/2012 | EP2408802A1 Cyclic amino acid molecules and methods of preparing the same |
| 01/25/2012 | EP2408801A1 Peptides used in the treatment and/or care of the skin, mucous membranes and/or scalp and their use in cosmetic or pharmaceutical compositions |
| 01/25/2012 | EP2408462A1 Targeted delivery of chemotherapeutic agents |
| 01/25/2012 | CN1982330B Methods for preparing purified lipopeptides |
| 01/25/2012 | CN102333867A C1orf59 peptides and vaccines including the same |
| 01/25/2012 | CN102329376A Cyclo(phenylalanine-N-methylleucyl-leucyl-N-methylleucyl-leucyl), and synthesis method and application thereof |
| 01/25/2012 | CN102329375A Group of terminal-amidated antibacterial peptides |
| 01/25/2012 | CN102329374A Gastric-cancer targeted peptide and application thereof |
| 01/25/2012 | CN102329373A Solid-phase synthetic process for degarelix |
| 01/25/2012 | CN101906146B Conjugate produced by coupling Arg-Gly-Asp-Ser chain with two fatty alcohol chains through Asp, synthesis of Arg-Gly-Asp-Ser chain and fatty alcohol chains and application in medicine |
| 01/25/2012 | CN101747414B Tumor necrosis factor (TNF)-alpha binding peptide and tumor necrosis factor receptor 1(TNFR1) blocking peptide and applications thereof in treatment of TNF related diseases |
| 01/25/2012 | CN101638429B Small molecular peptide of specificity recognition cell surface integrin alphal3beta1 |
| 01/24/2012 | USRE43140 Immunoregulator |
| 01/24/2012 | US8101712 Extracting impurities from broth having echinocandin compound with non polar water-immiscible organic solvent to obtain first two-phase system comprising aqueous phase and organic phase, removing organic phase, extracting echinocandin from aqueous phase with water-immiscible solvent |
| 01/24/2012 | US8101579 Methods and compositions for the treatment of gastrointestinal disorders |
| 01/24/2012 | US8101578 Amyloid [β] Beta fibrillogenesis-inhibiting peptide |
| 01/24/2012 | US8101573 α-conotoxin MII analogs |
| 01/24/2012 | CA2492848C Isolation and identification of t cells |
| 01/24/2012 | CA2439428C Molecular mimetics of meningococcal b epitopes which elicit functionally active antibodies |
| 01/24/2012 | CA2370763C Peptide epitopes recognized by disease promoting cd4+ t lymphocytes |
| 01/24/2012 | CA2295691C Methods and compositions for impairing multiplication of hiv-1 |
| 01/19/2012 | WO2012009705A1 Ang-2 binding complexes and uses thereof |
| 01/19/2012 | WO2012009447A2 THE cAMP/PKA/HDAC5 PATHWAY AND USES THEREOF |
| 01/19/2012 | WO2012007622A1 Method for the differential diagnosis of chagas disease |
| 01/19/2012 | WO2012006732A1 Affinity purification of rna under native conditions based on the lambda boxb/n peptide interaction |
| 01/19/2012 | WO2011131896A3 Peptide derivatives, preparation thereof and uses thereof as vectors |
| 01/19/2012 | US20120016340 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 01/19/2012 | US20120016103 Pepstatin a derivatives |
| 01/19/2012 | US20120016102 Non-toxic biofilm inhibitor |
| 01/19/2012 | US20120015885 COMPOSITIONS AND METHODS FOR CaMKII INHIBITORS AND USES THEREOF |
| 01/19/2012 | US20120015884 Polypeptides for Specific Targeting to Otx2 Target Cells |
| 01/19/2012 | US20120015883 Peptoid and synthetic oligomers, pharmaceutical compositions and methods of using same |
| 01/19/2012 | US20120015878 Use of adnf polypeptides for treating anxiety and depression |
| 01/19/2012 | US20120015873 Melanocortin analogs with antimicrobial activity |
| 01/19/2012 | US20120015870 Peptides and compositions for prevention of cell adhesion and methods of using same |
| 01/19/2012 | US20120015868 Metastin derivatives and use thereof |
| 01/19/2012 | US20120015867 Therapeutic peptides and method |
| 01/19/2012 | US20120014977 NOVEL ALTERNATIVE SPLICING VARIANT OF OATP1B3 mRNA |
| 01/19/2012 | US20120014958 Stable and soluble antibodies inhibiting vegf |
| 01/19/2012 | US20120014925 Self-Assembling Peptides Incorporating Modifications and Methods of Use Thereof |
| 01/19/2012 | US20120014874 Photosensitizer-metal nanoparticle charge complex and composition containing the complex for photodynamic therapy or diagnosis |
| 01/19/2012 | US20120014873 Peptides whose uptake by cells is controllable |
| 01/19/2012 | CA2802207A1 Materials and method for suppressing inflammatory and neuropathic pain |
| 01/18/2012 | EP2407479A1 Self-assembling peptide and peptide gel with high strength |
| 01/18/2012 | EP2406275A1 Peptide promoting cell adhesion and migration |
| 01/18/2012 | EP2406238A1 Metal ion chelating agents, methods for preparing same and uses thereof |
| 01/18/2012 | EP2271665B1 Highly bridged peptides from actinomadura namibiensis |
| 01/18/2012 | EP1950294B1 Novel cell penetrating peptide |
| 01/18/2012 | EP1696945B1 Self-assembling peptide amphiphiles and related methods for growth factor delivery |
| 01/18/2012 | EP1292709B1 Conjugate addition reactions for the controlled delivery of pharmaceutically active compounds |
| 01/18/2012 | CN102325788A Cancer-targeting peptides and uses thereof in cancer therapy |
| 01/18/2012 | CN102325787A Novel antibacterial agents for the treatment of gram positive infections |
| 01/18/2012 | CN102325785A Process for purifying lipopeptides |
| 01/18/2012 | CN102321159A Photosensitizer with tumor targeting and preparation method thereof |
| 01/18/2012 | CN102321158A Polypeptide for preventing cell DNA synthesis and inhibiting cell proliferation and application |
| 01/18/2012 | CN102321157A Hexapeptide with antioxidant activity and separation method as well as application thereof |